Cue Health to Present at the BTIG MedTech, Digital Health, Life Science & Diagnostic Tools Conference

Rhea-AI Summary

Cue Health (Nasdaq: HLTH) will present at the BTIG MedTech, Digital Health, Life Science & Diagnostic Tools Conference on February 15, 2022 at 12:30 p.m. ET. The webcast is exclusive for conference attendees. Founded in 2010 and based in San Diego, Cue Health focuses on accessible health information, enabling real-time diagnostics for individuals and healthcare providers. They gained recognition for their pioneering COVID-19 test, the first FDA-authorized at-home molecular diagnostic test. Cue Health holds multiple international regulatory approvals.

SAN DIEGO--(BUSINESS WIRE)-- Cue Health (“Cue”) (Nasdaq: HLTH), a healthcare technology company, announced today that its management team will present at the BTIG MedTech, Digital Health, Life Science & Diagnostic Tools Conference on Tuesday, February 15, 2022 at 12:30 p.m. Eastern Time.

The webcast link is available only for those who are attending the BTIG conference.

About Cue Health

Cue Health (Nasdaq: HLTH) is a healthcare technology company that makes it easy for individuals to access health information and places diagnostic information at the center of care. Cue Health enables people to manage their health through real-time, actionable, and connected health information, offering individuals and their healthcare providers easy access to lab-quality diagnostics anywhere, anytime, in a device that fits in the palm of the hand. Cue Health's first-of-its-kind COVID-19 test was the first FDA-authorized molecular diagnostic test for at-home and over-the-counter use without a prescription and physician supervision. Outside the United States, Cue Health has received the CE mark in the European Union, Interim Order authorization from Health Canada, regulatory approval from India's Central Drugs Standard Control Organization, and PSAR authorization from Singapore’s Health Sciences Authority. Cue was founded in 2010 and is headquartered in San Diego. For more information, please visit www.cuehealth.com.

View source version on businesswire.com: https://www.businesswire.com/news/home/20220201006062/en/

ICR Westwicke

Caroline Corner

ir@cuehealth.com

(415) 202-5678

Cue Health

press@cuehealth.com

Source: Cue Health Inc.

FAQ

When will Cue Health present at the BTIG conference?

Cue Health will present on February 15, 2022, at 12:30 p.m. Eastern Time.

What is the significance of Cue Health's COVID-19 test?

Cue Health's COVID-19 test was the first FDA-authorized molecular diagnostic test for at-home use without a prescription.

Where is Cue Health headquartered?

Cue Health is headquartered in San Diego, California.

What regulatory approvals has Cue Health received for its products?

Cue Health has received FDA authorization, CE mark in the EU, Health Canada's Interim Order, and approvals from India's CDSCO and Singapore's HSA.

What type of company is Cue Health?

Cue Health is a healthcare technology company that provides accessible lab-quality diagnostics and health information.